Loading: 100%
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reasons:
- It is not known how cost items are reported in the original P&L
- Not all line items from the original statement have been associated with a standardised figure (11 items missing)
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net sales
1,788
1,842
1,879
1,955
1,939
1,970
2,151
Cost of goods sold
1,289
1,315
1,341
1,389
1,378
1,466
1,607
Gross Profit
499
527
539
566
561
504
544
Depreciation and amortization
26
29
34
40
41
41
46
Selling, general and administrative expenses
434
451
453
488
481
511
509
Operating income (loss)
38
47
51
39
39
-48
-10
Interest income
0
0
0
0
0
0
0
Interest expense
0
0
1
1
0
1
1
INCOME (LOSS) BEFORE INCOME TAXES
38
47
51
39
39
-49
-12
Provision (benefit) for income taxes
15
17
17
9
13
-20
-4
Net Income (Loss)
24
30
33
30
26
-29
-7
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Balance SheetBS data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (32 items missing)
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash and cash equivalents
n/a
49
27
8
7
6
6
Receivables, less allowance for doubtful accounts
n/a
28
32
35
35
41
53
Inventories
n/a
313
332
353
362
316
341
Other non-trade receivables
n/a
26
32
33
39
43
40
Prepaid expenses and other current assets
n/a
13
12
13
13
13
11
Total current assets
n/a
430
435
443
456
420
451
Property and equipment, less accumulated depreciation and amortization
n/a
140
161
158
153
144
139
Equipment under capital leases, less accumulated amortization
n/a
0
0
0
0
0
0
Intangible assets, net
n/a
22
32
42
55
0
0
Goodwill
n/a
0
0
0
0
0
41
Other intangibles, net
n/a
0
0
0
0
80
97
Other noncurrent assets, net
n/a
4
3
3
4
3
2
Total assets
n/a
596
632
647
668
646
731
Liabilities and owners' equity
Accounts payable
n/a
81 81002000
107 106886000
115 115325000
126 125925000
143 143250000
185 184657000
Current portion of indebtedness
n/a
0 201000
1 658000
1 1263000
2 1640000
4 4331000
1 621000
Deferred income taxes
n/a
21 21142000
24 23878000
24 24234000
24 24446000
0 0
0 0
Accrued expenses and other
n/a
45 45371000
45 44876000
44 44000000
46 46236000
46 45599000
56 56074000
Total current liabilities
n/a
148 147716000
176 176298000
185 184822000
198 198247000
193 193180000
241 241352000
Long-term portion of indebtedness
n/a
4 3969000
7 6640000
12 12241000
4 3578000
2 2259000
53 52527000
Deferred income taxes
n/a
2 2069000
6 5633000
5 4732000
0 0
11 10615000
10 9724000
Other noncurrent liabilities
n/a
18 17886000
20 19799000
14 13581000
14 14413000
25 24785000
23 22698000
Total liabilities
n/a
172 171640000
208 208370000
215 215376000
216 216238000
231 230839000
326 326301000
Commitments and contingencies
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Preferred stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Common stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Retained earnings
n/a
292 291649000
317 317364000
331 331136000
348 348321000
310 310413000
294 294140000
Accumulated other comprehensive income
n/a
1 872000
1 864000
1 794000
1 703000
1 570000
0 475000
Total shareholders' equity
n/a
424 423888000
424 423612000
431 431272000
452 451548000
416 415636000
404 404211000
Total liabilities and shareholders' equity
n/a
596 595528000
632 631982000
647 646648000
668 667786000
646 646475000
731 730512000
Remarks restated on n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (44 items missing)
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income (Loss)
24
30
33
30
26
-29
-7
Depreciation and amortization
26
29
34
40
41
41
46
Net gain on asset disposition
0
1
-3
0
-4
-4
-3
Provision for store closures and asset impairment
0
0
0
0
2
16
1
Stock-based compensation
2
2
2
2
2
2
2
Provision for uncollectible receivables
0
0
0
0
0
0
0
Provision (recovery) for uncollectible receivables
0
0
0
1
0
1
1
LIFO reserve increase
2
2
3
4
5
5
8
Benefit for postretirement medical
0
0
0
0
0
0
0
Deferred income tax benefit
6
2
6
-1
-5
-13
-1
Income tax benefit upon exercise of stock options
0
0
0
0
0
0
0
Trade and non-trade receivables
-2
-6
-8
-8
-5
2
-2
Insurance receivables
-1
1
0
0
0
0
0
Income tax benefit upon exercise of stock options
0
0
0
0
0
0
0
Income tax (charge) benefit upon exercise of stock options
0
0
0
0
0
0
0
Inventories
5
-22
-21
-25
-15
28
-31
Other assets
1
-1
1
-1
0
0
3
Accounts payable and accrued expenses
12
-1
25
8
13
17
29
Income taxes receivable
-8
4
-2
3
-1
-14
8
Other noncurrent liabilities
-3
1
2
-6
1
10
-2
Net cash provided by operating activities
64
42
73
45
59
64
51
Capital expenditures
-23
-27
-46
-27
0
0
0
Capital expenditures
-11
-11
-17
-20
-26
-23
-23
Proceeds from asset dispositions
0
0
3
2
6
5
4
Insurance recoveries for replacement assets
0
0
0
0
0
0
0
Asset acquisitions, net (primarily intangibles)
0
0
0
0
-25
-38
-17
Acquisition of Reeves-Sain Drug Store, Inc., net of cash
0
0
0
0
0
0
-43
Net cash used in investing activities
-33
-38
-59
-46
-45
-56
-79
Payments of indebtedness and capital lease obligations
0
-1
-1
-1
-1
-2
-1
Proceeds from revolving line of credit
0
0
0
78
235
455
937
Payments on revolving line of credit
0
0
0
-72
-242
-451
-903
Excess tax benefit (charges) from stock-based compensation
0
0
0
0
0
0
0
Debt issuance costs
0
0
0
0
0
0
0
Excess tax benefit (charges) from stock-based compensation
0
0
0
0
0
0
0
Excess tax benefit from stock-based compensation
0
0
0
0
0
0
0
Proceeds (payments) from exercise of stock options and employee stock purchase plan
0
1
0
1
1
0
2
Repurchase of shares
-7
-3
-28
-9
0
0
0
Cash dividends paid
-4
-6
-8
-16
-9
-9
-9
Net cash provided by (used in) financing activities
-11
-9
-36
-18
-16
-8
27
DECREASE IN CASH AND CASH EQUIVALENTS
20
-6
-22
-19
-1
0
-1
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Apr 18, 2013 n/a
calculated values,
restated on Apr 17, 2014 n/a
calculated values,
restated on Apr 16, 2015 n/a
calculated values,
restated on Apr 14, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Sumo